CROSSROADS STRATEGIES, LLC for EISAI, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54). Regulatory and legislative health care issues. 340B issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Medicare/Medicaid MMM
H.R.2404/S.1509, Treat and Reduce Obesity Act of 2015; Part D issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Budget/Appropriations BUD
S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; Drug Enforcement Administration (DEA) issues; H.CON.RES.27/S.CON.RES.11, Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.